{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:12:47Z","timestamp":1783926767011,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41417-025-00992-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:34:01Z","timestamp":1764956041000},"page":"505-518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7142-1683","authenticated-orcid":false,"given":"FangFang","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qulian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"992_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.606540","volume":"10","author":"MC Delahaye","year":"2020","unstructured":"Delahaye MC, Salem KI, Pelletier J, Aurrand-Lions M, Mancini SJC. Toward therapeutic targeting of bone marrow leukemic niche protective signals in B-cell acute lymphoblastic leukemia. Front Oncol. 2020;10:606540.","journal-title":"Front Oncol"},{"key":"992_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12185-021-03085-y","volume":"113","author":"Z Liu","year":"2021","unstructured":"Liu Z, Li Y, Shi C. Monitoring minimal\/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy. Int J Hematol. 2021;113:337\u201343.","journal-title":"Int J Hematol"},{"key":"992_CR3","doi-asserted-by":"crossref","unstructured":"Panuciak K, Nowicka E, Mastalerczyk A, Zawitkowska J, Niedzwiecki M, Lejman M. Overview on aneuploidy in childhood B-cell acute lymphoblastic leukemia. Int J Mol Sci. 2023;24:8764.","DOI":"10.3390\/ijms24108764"},{"key":"992_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.exphem.2022.12.005","volume":"119-120","author":"AQ Lee","year":"2023","unstructured":"Lee AQ, Konishi H, Helmke E, Ijiri M, Lerot JMA, Hicks E, et al. Cmpd10357 to treat B-cell acute lymphoblastic leukemia. Exp Hematol. 2023;119-120:8\u201313.e1.","journal-title":"Exp Hematol"},{"key":"992_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1260839","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, Tang C, Wang M, Zhao H, Zhu Y. Ferroptosis as an emerging target in rheumatoid arthritis. Front Immunol. 2023;14:1260839.","journal-title":"Front Immunol"},{"key":"992_CR6","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.2147\/JIR.S432111","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Han Z, Wang Y, Su J, Lin Y, Cheng X, et al. Targeting ferroptosis in bone-related diseases: facts and perspectives. J Inflamm Res. 2023;16:4661\u201377.","journal-title":"J Inflamm Res"},{"key":"992_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"992_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"T Daolin","year":"2021","unstructured":"Daolin T, Xin C, Rui K, Guido K. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"992_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"992_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834681","volume":"12","author":"H Lan","year":"2022","unstructured":"Lan H, Gao Y, Zhao Z, Mei Z, Wang F. Ferroptosis: redox imbalance and hematological tumorigenesis. Front Oncol. 2022;12:834681.","journal-title":"Front Oncol"},{"key":"992_CR11","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00277-023-05293-4","volume":"102","author":"X Tang","year":"2023","unstructured":"Tang X, Wang Y, Zhu Y, Guo Y, Liu B. Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia. Ann Hematol. 2023;102:1985\u201399.","journal-title":"Ann Hematol"},{"key":"992_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586530","volume":"10","author":"E Grignano","year":"2020","unstructured":"Grignano E, Birsen R, Chapuis N, Bouscary D. From iron chelation to overload as a therapeutic strategy to induce ferroptosis in leukemic cells. Front Oncol. 2020;10:586530.","journal-title":"Front Oncol"},{"key":"992_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3324\/haematol.2022.280786","volume":"108","author":"ME Lalonde","year":"2023","unstructured":"Lalonde ME, Sasseville M, Gelinas AM, Milanese JS, Beland K, Drouin S, et al. Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. Haematologica. 2023;108:382\u201393.","journal-title":"Haematologica"},{"key":"992_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110607","volume":"499","author":"MH Schernthaner-Reiter","year":"2020","unstructured":"Schernthaner-Reiter MH, Trivellin G, Stratakis CA. Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway. Mol Cell Endocrinol. 2020;499:110607.","journal-title":"Mol Cell Endocrinol"},{"key":"992_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.semcancer.2020.02.004","volume":"68","author":"DR Perez","year":"2021","unstructured":"Perez DR, Sklar LA, Chigaev A, Matlawska-Wasowska K. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias\u2014a missed opportunity. Semin Cancer Biol. 2021;68:199\u2013208.","journal-title":"Semin Cancer Biol"},{"key":"992_CR16","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-136131","volume":"22","author":"H Afshari","year":"2023","unstructured":"Afshari H, Noori S, Shokri B, Zarghi A. Co-treatment of naringenin and ketoprofen-RGD suppresses cell proliferation via calmodulin\/PDE\/cAMP\/PKA axis pathway in leukemia and ovarian cancer cells. Iran J Pharm Res. 2023;22:e136131.","journal-title":"Iran J Pharm Res"},{"key":"992_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41419-020-2380-9","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Chen J, Yang W, Liu H, Wang J, Xiao J, et al. mPGES-1\/PGE2 promotes the growth of T-ALL cells in vitro and in vivo by regulating the expression of MTDH via the EP3\/cAMP\/PKA\/CREB pathway. Cell Death Dis. 2020;11:221.","journal-title":"Cell Death Dis"},{"key":"992_CR18","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s00277-024-05821-w","volume":"103","author":"B Budak","year":"2024","unstructured":"Budak B, Tukel EY, Turanli B, Kiraz Y. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities. Ann Hematol. 2024;103:4121\u201334.","journal-title":"Ann Hematol"},{"key":"992_CR19","first-page":"5147","volume":"16","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zhao L, Wei X, Guo Q, Zhu X, Wei R, et al. Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML. Oncol Lett. 2018;16:5147\u201359.","journal-title":"Oncol Lett"},{"key":"992_CR20","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51:D571\u201382.","journal-title":"Nucleic Acids Res"},{"key":"992_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06019-0","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Qiu Y, Zhang H, Chang N, Hu Y, Chen J, et al. Histone acetylation by HBO1 (KAT7) activates Wnt\/beta-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia. Cell Death Dis. 2023;14:498.","journal-title":"Cell Death Dis"},{"key":"992_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-024-03681-x","volume":"98","author":"H Tang","year":"2024","unstructured":"Tang H, Kang R, Liu J, Tang D. ATF4 in cellular stress, ferroptosis, and cancer. Arch Toxicol. 2024;98:1025\u201341.","journal-title":"Arch Toxicol"},{"key":"992_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2023.101899","volume":"68","author":"X Ma","year":"2023","unstructured":"Ma X, Xu J, Gao N, Tian J, Song T. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury via inhibiting ferroptosis by the cAMP\/PKA\/CREB pathway. Mol Cell Probes. 2023;68:101899.","journal-title":"Mol Cell Probes"},{"key":"992_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/cas.15583","volume":"114","author":"T Yasuda","year":"2023","unstructured":"Yasuda T, Sanada M, Tsuzuki S, Hayakawa F. Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia. Cancer Sci. 2023;114:8\u201315.","journal-title":"Cancer Sci"},{"key":"992_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10238-023-01255-2","volume":"24","author":"LX Wu","year":"2024","unstructured":"Wu LX, Zhao MY, Yan N, Zhou YL, Cao LM, Qin YZ, et al. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia. Clin Exp Med. 2024;24:56.","journal-title":"Clin Exp Med"},{"key":"992_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.849437","volume":"13","author":"C Han","year":"2022","unstructured":"Han C, Zheng J, Li F, Guo W, Cai C. Novel prognostic signature for acute myeloid leukemia: bioinformatics analysis of combined CNV-driven and ferroptosis-related genes. Front Genet. 2022;13:849437.","journal-title":"Front Genet"},{"key":"992_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1647-8","volume":"16","author":"C Yang","year":"2018","unstructured":"Yang C, Shao T, Zhang H, Zhang N, Shi X, Liu X, et al. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. J Transl Med. 2018;16:267.","journal-title":"J Transl Med"},{"key":"992_CR28","doi-asserted-by":"publisher","first-page":"e106788","DOI":"10.1371\/journal.pone.0106788","volume":"9","author":"L Wang","year":"2014","unstructured":"Wang L, Yao ZQ, Moorman JP, Xu Y, Ning S. Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies. PLoS ONE. 2014;9:e106788.","journal-title":"PLoS ONE"},{"key":"992_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.freeradbiomed.2023.11.009","volume":"210","author":"X Guan","year":"2024","unstructured":"Guan X, Ruan Y, Che X, Feng W. Dual role of PRDX1 in redox-regulation and tumorigenesis: past and future. Free Radic Biol Med. 2024;210:120\u20139.","journal-title":"Free Radic Biol Med"},{"key":"992_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/ijlh.14319","volume":"46","author":"XS Yan","year":"2024","unstructured":"Yan XS, Sun YJ, Du J, Niu WY, Qiao H, Yin XC. Effects of ferroptosis-related gene HSPB1 on acute myeloid leukemia. Int J Lab Hematol. 2024;46:899\u2013909.","journal-title":"Int J Lab Hematol"},{"key":"992_CR31","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101610R","volume":"36","author":"Y Lin","year":"2022","unstructured":"Lin Y, Shen X, Ke Y, Lan C, Chen X, Liang B, et al. Activation of osteoblast ferroptosis via the METTL3\/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. FASEB J. 2022;36:e22147.","journal-title":"FASEB J"},{"key":"992_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00432-024-05748-9","volume":"150","author":"W Shi","year":"2024","unstructured":"Shi W, Wang J, Chen J, Jin X, Wang Y, Yang L. Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1\/JNK pathway. J Cancer Res Clin Oncol. 2024;150:218.","journal-title":"J Cancer Res Clin Oncol"},{"key":"992_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08996-6","volume":"23","author":"WK Shi","year":"2022","unstructured":"Shi WK, Liu YX, Qiu XY, Zhou JY, Zhou JL, Lin GL. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer. BMC Genom. 2022;23:764.","journal-title":"BMC Genom"},{"key":"992_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10688-7","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Liu J, Liu S. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma. BMC Cancer. 2023;23:229.","journal-title":"BMC Cancer"},{"key":"992_CR35","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10637-021-01114-5","volume":"39","author":"CJ Qiu","year":"2021","unstructured":"Qiu CJ, Wang XB, Zheng ZR, Yang CZ, Lin K, Zhang K, et al. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Investig New Drugs. 2021;39:1507\u201322.","journal-title":"Investig New Drugs"},{"key":"992_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal. 2024;22:7.","journal-title":"Cell Commun Signal"},{"key":"992_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.23736\/S0031-0808.20.03978-6","volume":"65","author":"C Song","year":"2023","unstructured":"Song C, Xiong G, Yang S, Wei X, Ye X, Huang W, et al. PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt\/beta-Catenin signaling. Panminerva Med. 2023;65:37\u201342.","journal-title":"Panminerva Med"},{"key":"992_CR38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/ijc.34999","volume":"155","author":"Y Shen","year":"2024","unstructured":"Shen Y, You Z, Li L, Tang X, Shan X. The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis. Int J Cancer. 2024;155:1290\u2013302.","journal-title":"Int J Cancer"},{"key":"992_CR39","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.7150\/jca.37147","volume":"11","author":"E Lu","year":"2020","unstructured":"Lu E, Hu X, Pan C, Chen J, Xu Y, Zhu X. Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer. J Cancer. 2020;11:1170\u201381.","journal-title":"J Cancer"},{"key":"992_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06047-w","volume":"14","author":"Y Feng","year":"2023","unstructured":"Feng Y, Zhang T, Zhang Z, Liang Y, Wang H, Chen Y, et al. The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. Cell Death Dis. 2023;14:551.","journal-title":"Cell Death Dis"},{"key":"992_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.56","volume":"8","author":"L Komorowski","year":"2024","unstructured":"Komorowski L, Dabkowska A, Madzio J, Pastorczak A, Szczygiel K, Janowska M, et al. Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors. Hemasphere. 2024;8:e56.","journal-title":"Hemasphere"},{"key":"992_CR42","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.7150\/ijbs.99804","volume":"20","author":"Y Song","year":"2024","unstructured":"Song Y, Wang X, Sun Y, Yu N, Tian Y, Han J, et al. PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer. Int J Biol Sci. 2024;20:5070\u201386.","journal-title":"Int J Biol Sci"},{"key":"992_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103392","volume":"77","author":"W Lai","year":"2024","unstructured":"Lai W, Zhu W, Wu J, Huang J, Li X, Luo Y, et al. HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1. Redox Biol. 2024;77:103392.","journal-title":"Redox Biol"},{"key":"992_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11427-023-2425-2","volume":"67","author":"X Fan","year":"2024","unstructured":"Fan X, Liu F, Wang X, Wang Y, Chen Y, Shi C, et al. LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation. Sci China Life Sci. 2024;67:488\u2013503.","journal-title":"Sci China Life Sci"},{"key":"992_CR45","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1111\/jcmm.17529","volume":"26","author":"C Gong","year":"2022","unstructured":"Gong C, Ji Q, Wu M, Tu Z, Lei K, Luo M, et al. Ferroptosis in tumor immunity and therapy. J Cell Mol Med. 2022;26:5565\u201379.","journal-title":"J Cell Mol Med"},{"key":"992_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","volume":"5","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, Porter AH, Song A, Vroeg In de Wei G, Stoll T, Straube J, et al. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer. 2024;5:47\u201365.","journal-title":"Nat Cancer"},{"key":"992_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Wang H, Yang X, Wu Q, An P, Jin X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5:138.","journal-title":"Signal Transduct Target Ther"},{"key":"992_CR48","doi-asserted-by":"crossref","unstructured":"Bajor M, Graczyk-Jarzynka A, Marhelava K, Kurkowiak M, Rahman A, Aura C, et al. Triple Combination of ascorbate, menadione and the inhibition of peroxiredoxin-1 produces synergistic cytotoxic effects in triple-negative breast cancer cells. Antioxidants. 2020;9:320.","DOI":"10.3390\/antiox9040320"},{"key":"992_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang A, Fan T, Liu Y, Yu G, Li C, Jiang Z. Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol Cancer. 2024;23:251.","journal-title":"Mol Cancer"},{"key":"992_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35:109235.","journal-title":"Cell Rep"},{"key":"992_CR51","doi-asserted-by":"publisher","first-page":"9508702","DOI":"10.1155\/2021\/9508702","volume":"2021","author":"L Jiao","year":"2021","unstructured":"Jiao L, Wei J, Ye J, Zhang C. Prognostic value of peroxiredoxin-1 expression in patients with solid tumors: a meta-analysis of cohort study. Dis Markers. 2021;2021:9508702.","journal-title":"Dis Markers"},{"key":"992_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07831-6","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Liu G, Chen Z, Li K, Yu Z, He C, et al. Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis. Cell Death Dis. 2025;16:627.","journal-title":"Cell Death Dis"},{"key":"992_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jcmm.12955","volume":"21","author":"C Ding","year":"2017","unstructured":"Ding C, Fan X, Wu G. Peroxiredoxin 1\u2014an antioxidant enzyme in cancer. J Cell Mol Med. 2017;21:193\u2013202.","journal-title":"J Cell Mol Med"},{"key":"992_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114682","volume":"43","author":"HR Chen","year":"2024","unstructured":"Chen HR, Sun Y, Mittler G, Rumpf T, Shvedunova M, Grosschedl R, et al. MOF-mediated PRDX1 acetylation regulates inflammatory macrophage activation. Cell Rep. 2024;43:114682.","journal-title":"Cell Rep"},{"key":"992_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol. 2020;9:32.","journal-title":"Exp Hematol Oncol"},{"key":"992_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41418-024-01407-1","volume":"32","author":"C Liu","year":"2025","unstructured":"Liu C, Zhang C, Wu H, Zhao Z, Wang Z, Zhang X, et al. The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma. Cell Death Differ. 2025;32:506\u201320.","journal-title":"Cell Death Differ"},{"key":"992_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-023-01630-8","volume":"9","author":"L Li","year":"2023","unstructured":"Li L, Xing T, Chen Y, Xu W, Fan B, Ju G, et al. In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-gamma-induced ferroptosis of hepatocellular carcinoma. Cell Death Discov. 2023;9:331.","journal-title":"Cell Death Discov"},{"key":"992_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02567-3","volume":"24","author":"G Shan","year":"2023","unstructured":"Shan G, Bi G, Zhao G, Liang J, Bian Y, Zhang H, et al. Inhibition of PKA\/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer. Respir Res. 2023;24:277.","journal-title":"Respir Res"},{"key":"992_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.freeradbiomed.2023.06.006","volume":"205","author":"J Nie","year":"2023","unstructured":"Nie J, Zhang P, Liang C, Yu Y, Wang X. ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer. Free Radic Biol Med. 2023;205:318\u201331.","journal-title":"Free Radic Biol Med"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00992-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00992-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00992-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:02:43Z","timestamp":1783926163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00992-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00992-8","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the animal experiments were approved by the Animal Care and Use Committee of the Affiliated Hospital of Southwest Medical University and were conducted in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals. The study is reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}